Cited by 877Immunotherapy and Immune ResponsesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Open access

Munn, David H., Sharma, Madhav D., Hou, Deyan, Baban, Babak, Lee, Jeffrey R., Antonia, Scott J., Messina, Jane L., Chandler, Phillip, Koni, Pandelakis A., Mellor, Andrew L.·2004·Journal of Clinical Investigation

DOI 10.1172/jci21583

Open this paper in CoChat — free account Open PDF

Abstract

One mechanism contributing to immunologic unresponsiveness toward tumors may be presentation of tumor antigens by tolerogenic host APCs.We show that mouse tumor-draining LNs (TDLNs) contained a subset of plasmacytoid DCs (pDCs) that constitutively expressed immunosuppressive levels of the enzyme indoleamine 2,3-dioxygenase (IDO).Despite comprising only 0.5% of LN cells, these pDCs in vitro potently suppressed T cell responses to antigens presented by the pDCs themselves and also, in a dominant fashion, suppressed T cell responses to third-party antigens presented by nonsuppressive APCs.Adoptive transfer of DCs from TDLNs into naive hosts created profound local T cell anergy, specifically toward antigens expressed by the transferred DCs.Anergy was prevented by targeted disruption of the IDO gene in the DCs or by administration of the IDO inhibitor drug 1-methyl-D-tryptophan to recipient mice.Within the population of pDCs, the majority of the functional IDO-mediated suppressor activity segregated with a novel subset of pDCs coexpressing the B-lineage marker CD19.We hypothesize that IDO-mediated suppression by pDCs in TDLNs creates a local microenvironment that is potently suppressive of host antitumor T cell responses.Nonstandard abbreviations used: indoleamine 2,3-dioxygenase (IDO); 1-methyl-D-tryptophan (1MT); mixed leukocyte reaction (MLR); plasmacytoid DC (pDC); regulatory T cell (Treg); T cell receptor (TCR); tumor-draining LN (TDLN). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci21583

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

T cell receptor antagonist peptides induce positive selection.
Hogquist, K., Jameson, S., Heath, W., Howard, J. L., Bevan, M., & Carbone, F. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 3,252
Tolerogenic Dendritic Cells
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Dranoff, G., Jaffee, E. M., Lazenby, A., Golumbek, P. T., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. M., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,820
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589
Self-citation
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I. E., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,640
Self-citation
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,375
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,204
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y.-C., Golumbek, P. T., Ahmadzadeh, M., Jaffee, E. M., Pardoll, D. M., & Levitsky, H. I. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,159

Flagged first, then by citations

Show all 85 references

Research works printed but not linked: 2

Cuenca, 2003, Cancer Res., 63, 9007
Almand, 2000, Clin. Cancer Res., 6, 1755

Sorted by citations

Items 601–700 of 877

Schlafen4+-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases
Ding, L., Sheriff, S., Sontz, R. A., & Merchant, J. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139391 · Cited by 16
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective
Yang, H., Wu, C.-Y., Powell, J. D., & Lu, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114030 · Cited by 17
The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase
Duff, M. R., Gabel, S. A., Pedersen, L. C., DeRose, E. F., Krahn, J. M., Howell, E. E., & London, R. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00546 · Cited by 16
Increased TTS abrogates IDO-mediated CD4+ T cells suppression in patients with Graves’ disease
Wang, S., Mao, C., Zhao, Z., Gu, Q., Jin, M., Xiao, Y., Jiang, X., Zhao, Y., Zhang, Y., & Ning, G. (2009) · Endocrine · doi:10.1007/s12020-009-9184-0 · Cited by 16
TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells
Narusawa, M., Inoue, H., Sakamoto, C., Matsumura, Y., Takahashi, A., Inoue, T., Watanabe, A., Miyamoto, S., Miura, Y., Hijikata, Y., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0143 · Cited by 17
Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis
Canavese, M., Wijesundara, D. K., Maddern, G. J., Grubor‐Bauk, B., & Hauben, E. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.55 · Cited by 16
The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model
Liu, K., Yang, Y., Chen, Y., Li, S., Gong, Y., & Liang, Y. (2020) · International Urology and Nephrology · doi:10.1007/s11255-019-02365-1 · Cited by 16
Placental expression of indoleamine 2,3-dioxygenase
Sedlmayr, P., & Blaschitz, A. (2012) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-012-0082-3 · Cited by 16
Dendritic cell vaccines: Current research progress, challenges, and opportunities
Zhang, S., Mo, S., Huang, W., Zhong, D., Yang, X., Xie, S., Liu, A., Mo, F., Huang, X., Liu, H., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101913 · Cited by 15
Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
Pan, J., Lin, Y., Liu, X., Zhang, X., Liang, T., & Bai, X. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01099-4 · Cited by 16
Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells
Park, S., & Moon, Y. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.742535 · Cited by 15
Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer
Salvadori, M. L. B., Bianchi, P. K. F. D. C., Gebrim, L. H., Silva, R. S., & Kfoury, J. R. (2015) · Medical Oncology · doi:10.1007/s12032-015-0694-8 · Cited by 15
The role of the immunoescape in colorectal cancer liver metastasis
Takasu, C., Yamashita, S., Morine, Y., Yoshikawa, K., Tokunaga, T., Nishi, M., Kashihara, H., Yoshimoto, T., & Shimada, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259940 · Cited by 15
B Cells Are Not Involved in the Regulation of Adenoviral TGF-β1– or Bleomycin-Induced Lung Fibrosis in Mice
Moog, M., Hinze, C. A., Bormann, T., Aschenbrenner, F., Knudsen, L., DeLuca, D. S., Jonigk, D. D., Neubert, L., Welte, T., Gauldie, J., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100767 · Cited by 16
Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis
Oertelt‐Prigione, S., Mao, T. K., Selmi, C. F., Tsuneyama, K., Ansari, A. A., Coppel, R. L., Invernizzi, P., Podda, M., & Gershwin, M. E. (2008) · Autoimmunity · doi:10.1080/08916930701619730 · Cited by 15
Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies
Johnson, T. S., Munn, D. H., & Maria, B. L. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/937253 · Cited by 15
Self-citation
The Ubiquitin E3 Ligase Cbl-b in T Cells Tolerance and Tumor Immunity
Loeser, S., & Penninger, J. M. (2007) · Cell Cycle · doi:10.4161/cc.6.20.4797 · Cited by 15
Interaction of Immune and Cancer Cells
Klink, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4 · Cited by 15
T cell-mediated immunotherapy of metastases: state of the art in 2005
Schirrmacher, V. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.8.1051 · Cited by 15
Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how
Zhai, Y., Liang, X., & Deng, M. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.04 · Cited by 14
Concept of Reverse Costimulation and Its Role in Diseases
Mir, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802585-7.00002-9 · Cited by 14
Indoleamine 2,3-dioxygenase 1 signaling orchestrates immune tolerance in Echinococcus multilocularis-infected mice
Meng, R., Fu, Y., Zhang, Y., Mou, Y., Liu, G., & Fan, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032280 · Cited by 14
An exploratory study of the interplay between decreased concentration of tryptophan, accumulation of kynurenines, and inflammatory arthritis
Kolodziej, L. R. (2012) · IUBMB Life · doi:10.1002/iub.1092 · Cited by 14
Immunoprotective Role of Indoleamine 2,3-Dioxygenase in Engraftment of Allogenic Skin Substitute in Wound Healing
Bahar, M. A., Nabai, L., & Ghahary, A. (2012) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318235836e · Cited by 14
Plasmacytoid Dendritic Cells Respond Directly to Apoptotic Cells by Secreting Immune Regulatory IL-10 or IFN-α
Simpson, J. E., Miles, K., Trüb, M., MacMahon, R., & Gray, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00590 · Cited by 14
The Role of Plasmacytoid Dendritic Cells in Gut Health
Won, H.-Y., Lee, J., Ryu, D., Kim, H.-T., & Chang, S. (2019) · Immune Network · doi:10.4110/in.2019.19.e6 · Cited by 14
Self-citation
Function and dysfunction of dendritic cells in autoimmune rheumatic diseases
Rutella, S., CRISTOFARO, R. D., & Ferraccioli, G. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.01.023 · Cited by 14
Association between IDO activity and prognosis in patients with non-small cell lung cancer after radiotherapy
Zhu, Y., Jiang, C., Liu, Y., Li, Y., Wu, H., Feng, J., & Xu, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5634 · Cited by 13
Tolerogenic IDO1+CD83− Langerhans Cells in Sentinel Lymph Nodes of Patients with Melanoma
Gerlini, G., Gennaro, P. D., Pimpinelli, N., Sestini, S., & Borgognoni, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073441 · Cited by 13
The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth
Baban, B., Penberthy, W. T., & Mozaffari, M. S. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0009-2 · Cited by 13
Self-citation
Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy
Holtzhausen, A., Zhao, F. L., Evans, K. S., & Hanks, B. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00438 · Cited by 12
Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay
de Iudicibus, R. C., Tomek, P., Palmer, B. D., Tijono, S., Flanagan, J. U., & Ching, L. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116160 · Cited by 12
Inhibitory RNA Molecules in Immunotherapy for Cancer
Mao, C.-P., & Wu, T. ‐. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-588-0_21 · Cited by 12
Antigen Choice Determines Vaccine-Induced Generation of Immunogenic versus Tolerogenic Dendritic Cells That Are Marked by Differential Expression of Pancreatic Enzymes
Farkas, A. M., Marvel, D., & Finn, O. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203321 · Cited by 12
Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease
Zaatari, M. E., & Kao, J. Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00051 · Cited by 12
Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression
Colvin, B. L., Sumpter, T. L., Tokita, D., Salati, J., Mellor, A. L., & Thomson, A. W. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.01.021 · Cited by 14
Self-citation
Plasmacytoid Precursor Dendritic Cells From NOD Mice Exhibit Impaired Function
Huang, Y., Vivier, I., Miller, T., Elliott, M. J., Xu, H., Bozulic, L. D., Chilton, P. M., & Ildstad, S. T. (2008) · Diabetes · doi:10.2337/db08-0356 · Cited by 12
Lymphoma Immunotherapy: Vaccines, Adoptive Cell Transfer and Immunotransplant
Brody, J., & Levy, R. (2009) · Immunotherapy · doi:10.2217/imt.09.50 · Cited by 13
Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
Quan, J., Tan, P., MacDonald, A., & Friend, P. J. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1705 · Cited by 13
Interrogating the roles of lymph node metastasis in systemic immune surveillance
Basto, P. A., & Reticker-Flynn, N. E. (2024) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10261-3 · Cited by 11
Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation
Mangaonkar, A. A., & Patnaik, M. M. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2056175 · Cited by 11
Utility of Kynurenic Acid for Non-Invasive Detection of Metastatic Spread to Lymph Nodes in Non-Small Cell Lung Cancer
Sagan, D., Kocki, T., Patel, S., & Kocki, J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.7541 · Cited by 11
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model
Foureau, D., McKillop, I. H., Jones, C. P., Amin, A., White, R. L., & Salo, J. C. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1035-1 · Cited by 11
The HLA-G non classical MHC class I molecule is expressed in cancer with poor prognosis. Implications in tumour escape from immune system and clinical applications
Menier, C., Rouas‐Freiss, N., & Carosella, E. D. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44529 · Cited by 11
Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response
Diaz, Y., Tundidor, Y., Lopez, A., & León, K. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1345-y · Cited by 11
D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer
Zhang, Y., Li, Y., Liu, Z., Jiao, Y., Guo, J., Ren, W., Li, R., Zhu, G., Li, M., Li, X., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108203 · Cited by 11
The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
Jalili, R. B., Forouzandeh, F., Bahar, M. A., & Ghahary, A. (2007) · PubMed · Cited by 11
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy
Huarte, E., Tirapu, I., Arina, A., Vera, M., Alfaro, C., Murillo, O., Palencia, B., Busto, V., Marín, V., Mazzolini, G. D., et al. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.7 · Cited by 11
Melanoma and Immunosuppression
Fortina, A. B., Piaserico, S., Tonin, E., & Alaibac, M. (2008) · Dermatology · doi:10.1159/000161125 · Cited by 12
Vaccine strategies to treat lymphoproliferative disorders
Radford, K. J., Vari, F., & Hart, D. N. J. (2005) · Pathology · doi:10.1080/00313020500376462 · Cited by 11
IL-32–producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis
Dey, N. S., Dey, S., Brown, N., Senarathne, S., Reis, L. C., Sengupta, R., Lindoso, J. Â. L., James, S. R., Gilbert, L., Boucher, D., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci182040 · Cited by 11
Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA)
de la Cruz, G. P., de la Cruz, V. P., Cossio, J. Á. N., Cervantes, G. I. V., Salazar, A., Orozco‐Morales, M., & Pineda, B. (2023) · Pharmaceuticals · doi:10.3390/ph16030369 · Cited by 10
Tumor vaccines and beyond
Melenhorst, J. J., & Barrett, A. J. (2010) · Cytotherapy · doi:10.3109/14653249.2010.530649 · Cited by 10
Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics
Tan, P., & Lota, A. S. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.15.2639 · Cited by 10
Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts
Park, M.-K., Oh, H., Heo, Y., Park, E., Cho, M., Kim, H., & Park, S. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.8.050 · Cited by 10
Investigation of indolamine 2, 3 dioxygenase ( IDO‐1 ) gene expression by real‐time PCR among patients with lung cancer
Mazdarani, M. H., Jafarikia, M., & Nemati, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28057 · Cited by 10
The Role of Dendritic Cells and Monocytes in the Maintenance and Loss of Respiratory Tolerance
Hrusch, C. L., Tjota, M. Y., & Sperling, A. I. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0494-9 · Cited by 10
Disarming dendritic cells: a tumor strategy to escape from immune control?
Bella, S. D., Clerici, M., & Villa, M. L. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.3.411 · Cited by 10
Strategies of Antigen-Specific T-Cell–Based Immunotherapy for Cancer
Liu, S., Zhang, M., & Zhang, W. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.491 · Cited by 10
Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in micePreprint
Araujo, A. M., Dekker, J. D., Garrison, K., Su, Z., Rhee, C., Hu, Z., Lee, B., Osorio, D., Lee, J., Iyer, V. R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/310680 · Cited by 10
Self-citation
IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma
Liu, H., Gao, H., Chen, C., Jia, W., Xu, D., & Jiang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.904229 · Cited by 9
Formation of fluorophores from the kynurenine pathway metabolite N-formylkynurenine and cyclic amines involves transamidation and carbon–carbon bond formation at the 2-position of the amine
Tomek, P., Palmer, B. D., Kendall, J. D., Flanagan, J. U., & Ching, L. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.04.007 · Cited by 9
Overexpression of indoleamine 2, 3‑dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway
Jia, S., Guo, P., Ge, X., Wu, H., Lu, J., & Fan, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6163 · Cited by 9
Retracted
The Role of Indoleamine 2,3 Dioxygenase in Beneficial Effects of Stem Cells in Hind Limb Ischemia Reperfusion Injury
Masoumy, M., Yu, J. C.-K., Liu, J. Y., Yanasak, N. E., Middleton, C., Lamoke, F., Mozaffari, M. S., & Baban, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095720 · Cited by 9
Self-citation
Emerging Nanodelivery Strategies of RNAi Molecules for Colon Cancer Therapy: Preclinical Developments
Binkhathlan, Z., & Alshamsan, A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.89 · Cited by 9
Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target
Gill, D., & Tan, P. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.499360 · Cited by 9
The role of dendritic cells in neuroblastoma: Implications for immunotherapy
Zafari, R., Razi, S., & Rezaei, N. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152293 · Cited by 8
Dendritic cells in liver transplantation immune response
Du, X., Li, M., Huan, C., & Lv, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1277743 · Cited by 9
Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity
Lu, Y., Liu, X., & You, J. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102129 · Cited by 8
IDO in Inflammatory Programming and Immune Suppression in Cancer
Prendergast, G. C., Smith, C., Thomas, S., Mandik‐Nayak, L., Laury‐Kleintop, L. D., Metz, R. A., & Muller, A. J. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_11 · Cited by 8
Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting
Stroncek, D. F., Melief, C. J. M., Castiello, L., Cesano, A., Cheever, M. A., Civini, S., Comin-Anduix, B., Gajewski, T. F., Greenberg, P. D., Kaliński, P., et al. (2013) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-1-4 · Cited by 8
Self-citation
Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia
Sobash, P. T., Kolhe, R. B., Karim, N. A., Guddati, A. K., Jillella, A., & Kota, V. K. (2020) · Future Oncology · doi:10.2217/fon-2019-0642 · Cited by 8
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes
Blobner, J., Kilian, M., Tan, C. L., Aslan, K., Sanghvi, K., Meyer, J., Fischer, M. D., Jähne, K., Breckwoldt, M. O., Sahm, F., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab147 · Cited by 8
Inhibition of increased indoleamine 2,3-dioxygenase activity exacerbates neuronal cell death in various CNS disorders
Fujigaki, H., & Saito, K. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.050 · Cited by 8
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy
Gardner, J. K., Jackaman, C., Mamotte, C. D. S., & Nelson, D. J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00337 · Cited by 7
Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells
Liu, Y., Yeh, I., Lai, M., Liu, K., Kuo, P., & Yen, M. (2019) · Cancers · doi:10.3390/cancers11010108 · Cited by 7
Novel Biomarkers and Druggable Targets in Advanced Melanoma
Ferrucci, P. F., & Cocorocchio, E. (2021) · Cancers · doi:10.3390/cancers14010081 · Cited by 7
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors
Wilczyński, J. R., & Nowak, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_8 · Cited by 7
Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection
Lakshmanan, V., Alter, G., Altfeld, M. A., & Bhardwaj, N. (2007) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32810996db · Cited by 7
The Many Sounds of T Lymphocyte Silence
Melero, I., Arina, A., & Chen, L. (2005) · Immunologic Research · doi:10.1385/ir:33:2:135 · Cited by 7
Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice
Araujo, A. M., Dekker, J. D., Garrison, K., Su, Z., Rhee, C., Hu, Z., Lee, B., Osorio, D., Lee, J., Iyer, V. R., et al. (2024) · eLife · doi:10.7554/elife.96394 · Cited by 6
Self-citation
Recent update on the discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy
Gao, M., Yu, W., Xi, Z., Zhang, Z.-L., Fan, X., & Wang, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118017 · Cited by 8
Natural Killer Cell Recognition and Control of Epithelial Cancers
Pereira, M. D. S. F., Carr, D. R., Gatti-Mays, M. E., Olsen, M. R., Setty, B. A., Shahwan, K. T., & Lee, D. A. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000610 · Cited by 6
Alleviation of Rheumatoid Arthritis by Inducing IDO Expression with Trichinella spiralis Recombinant Protein 43
Ma, X., Liu, D., Yu, W., & Han, C. (2024) · Journal of Immunology Research · doi:10.1155/2024/8816919 · Cited by 6
Inhibitor of Indoleamine-2,3-Dioxygenase 1-Methyl-D-Tryptophan Can Stimulate the Growth of Immunogenic Tumors
Vasil’eva, E. D., Nikolin, V. P., Popova, N. A., Lushnikova, E. L., & Каледин, В. И. (2010) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-1009-x · Cited by 6
Optimized Protocols for siRNA Delivery into Monocytes and Dendritic Cells
Mobergslien, A., & Sioud, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-657-3_5 · Cited by 6
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
Lin, S., Yeh, T., Song, J., Hung, M., Cheng, M.-F., Liao, F.-Y., Li, A.-S., Cheng, S.-Y., Lin, L.-M., Chiu, C.-H., et al. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.02.010 · Cited by 6
Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients
Grzegorzewska, A. E., Winnicka, H., Warchol, W. J., Mostowska, A., & Jagodziński, P. P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.034 · Cited by 6
The role of plasmacytoid dendritic cells in immunity and tolerance
Chen, W. (2005) · Current Opinion in Organ Transplantation · doi:10.1097/01.mot.0000175464.98185.bf · Cited by 6
Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape.
Wang, H., Pan, K., & Xia, J. (2009) · PubMed · Cited by 6
Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges
Khanmiri, J. M., Khani-Eshratabadi, M., Seyedmoharrami, F., Khazaee‐Nasirabadi, M. H., Dehdashti, M., Seddighi, N., Peymaninezhad, F., Khiabani, A., Khanahmad, A., & Baradaran, B. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02056-z · Cited by 5
Selecting immuno-oncology–based drug combinations – what should we be considering?
Festino, L., Vanella, V., Trojaniello, C., & Ascierto, P. A. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1518713 · Cited by 6
Plasmacytoid dendritic cells in granulomatous variant of mycosis fungoides
Fernández‐Flores, A., & Cassarino, D. S. (2019) · Journal of Cutaneous Pathology · doi:10.1111/cup.13438 · Cited by 5
Novel therapeutic targets for chronic myelomonocytic leukemia
Lasho, T. L., & Patnaik, M. M. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101244 · Cited by 5
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
Farooq, A. V., Zulfiqar, B., & Asghar, K. (2023) · Journal of Cancer & Allied Specialties · doi:10.37029/jcas.v9i1.501 · Cited by 5
Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy
Lucas, S. N., & Thomas, S. N. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00692 · Cited by 5
Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium
Ibana, J. A., Cutay, S. J., Romero, M., & Schust, D. J. (2015) · Reproductive Sciences · doi:10.1177/1933719115602762 · Cited by 5
Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference
Sæbøe‐Larssen, S., & Sioud, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_14 · Cited by 5
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View
Raimondo, C. D., Lozzi, F., Domenico, P. P. D., Paganini, C., Campione, E., Galluzzo, M., & Bianchi, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137099 · Cited by 5
Immunotherapeutic Approaches in Cancer
Keshavarz‐Fathi, M., & Rezaei, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00002-3 · Cited by 6

Authors: Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L.
Affiliations: Augusta University (US)
University of South Florida (US)
Corresponding author: Munn, David H.
ORCID: Munn, David H.
Sharma, Madhav D.
Baban, Babak
Antonia, Scott J.
Messina, Jane L.
Koni, Pandelakis A.
Mellor, Andrew L.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 280-290
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci21583
OpenAlex: W2143565660
Cited by: 852
References: 85
Citations by year: 2026: 13 · 2025: 12 · 2024: 24 · 2023: 15 · 2022: 32 · 2021: 37 · 2020: 34 · 2019: 29 · 2018: 31 · 2017: 40 · 2016: 27 · 2015: 45 · 2014: 38 · 2013: 53 · 2012: 39
FWCI: 19.19
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed (publishedVersion)
Funders: Carlos and Marguerite Mason Trust
National Institutes of Health
National Cancer Institute (R01CA096651, R01 CA103220)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD041187)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: indoleamine 2,3-dioxygenase, plasmacytoid dendritic cells, tumor-draining lymph nodes, immunosuppression, T cell anergy, tumor antigen presentation, CD19, 1-methyl-D-tryptophan, antitumor immunity, regulatory T cells, mixed lymphocyte reaction
MeSH terms: Animals, Antigen-Presenting Cells, Dendritic Cells, Female, Humans, Immunosuppression Therapy, Lymph Nodes, Lymphocyte Activation, Mice, Inbred Strains, Neoplasms, Random Allocation, T-Lymphocytes, Tryptophan Oxygenase, Survival Rate, Mice, Knockout, Antigens, CD19, Adoptive Transfer, CD11c Antigen, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks